← Back to Search

DEXTENZA placed within the upper canaliculus for Ocular Pain

Phase 4
Waitlist Available
Research Sponsored by Kerry Assil, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed on days 1, 7, 30, 90 for change
Awards & highlights

Study Summary

This study is evaluating whether DEXTENZA is effective when placed in the upper eyelid canaliculus as opposed to the lower eyelid canaliculus.

Eligible Conditions
  • Ocular Pain
  • Ocular Inflammation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed on days 1, 7, 30, 90 for change
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed on days 1, 7, 30, 90 for change for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-op pain scores
Post-operative inflammation scores
Secondary outcome measures
Absence of CME
Absence of rebound iritis
Ease of Insertion (successful implantation)
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: DEXTENZA placed within the upper canaliculusExperimental Treatment1 Intervention
Dextenza placed within the upper canaliculus following bilateral cataract extraction surgery with posterior chamber intraocular lenses implantation.
Group II: DEXTENZA placed within the lower canaliculusActive Control1 Intervention
Dextenza placed within the lower canaliculus following bilateral cataract extraction surgery with posterior chamber intraocular lenses implantation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dexamethasone
FDA approved

Find a Location

Who is running the clinical trial?

Kerry Assil, MDLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025